Glass House Brands (GLAS) Assets (2020 - 2026)
Glass House Brands' (GLAS) quarterly Assets came in at $325.4 million in Q1 2026, up 4.42% year-on-year from $311.6 million in Q1 2025, and up 2.13% on a QoQ basis from $318.6 million in Q4 2025.
Glass House Brands (GLAS) Assets (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Assets data on file, last reported at $325.4 million in Q1 2026.
- On a quarterly basis, Assets rose 4.42% year-over-year to $325.4 million in Q1 2026; TTM through Mar 2026 was $325.4 million, a 4.42% increase from a year earlier, with the FY2025 full-year figure at $318.6 million, up 2.59% from the prior year.
- Assets for Q1 2026 stood at $325.4 million, up from $318.6 million in the prior quarter.
- Over the last five years, Assets for GLAS reached as high as $350.6 million in Q4 2022 and fell as low as $273.2 million in Q1 2022.
- Historically, Assets has averaged $318.2 million across 5 years, with a median of $318.6 million in 2025.
- On a YoY basis, Assets climbed as much as 6041.02% in 2022 and fell as far as 61.84% in 2022.
- Year by year, Assets stood at $350.6 million in 2022, then decreased by 13.36% to $303.8 million in 2023, then rose by 2.21% to $310.5 million in 2024, then grew by 2.59% to $318.6 million in 2025, then grew by 2.13% to $325.4 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $325.4 million in Q1 2026, $318.6 million in Q4 2025, and $319.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 6.71 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 25.35 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 325.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325.35 Mn |
| Dec 31, 2025 | 318.56 Mn |
| Sep 30, 2025 | 319.82 Mn |
| Jun 30, 2025 | 334.56 Mn |
| Mar 31, 2025 | 311.59 Mn |
| Dec 31, 2024 | 310.50 Mn |
| Sep 30, 2024 | 312.73 Mn |
| Jun 30, 2024 | 305.84 Mn |
| Mar 31, 2024 | 295.25 Mn |
| Dec 31, 2023 | 303.78 Mn |
| Sep 30, 2023 | 341.59 Mn |
| Jun 30, 2023 | 324.60 Mn |
| Mar 31, 2023 | 324.70 Mn |
| Dec 31, 2022 | 350.63 Mn |
| Sep 30, 2022 | 349.56 Mn |
| Jun 30, 2022 | 307.25 Mn |
| Mar 31, 2022 | 273.15 Mn |
| Dec 31, 2021 | 5.71 Mn |
| Sep 30, 2021 | 258.56 Mn |
| Jun 30, 2021 | 203.47 Mn |